Publications
- WT1 Gene Expression in Peripheral Blood Before and After Allogeneic Stem Cell Transplantation is a Clinically Relevant Prognostic Marker in AML - A Single-center 14-year Experience2021 | First Faculty of Medicine
- WT1 Expression in Peripheral Blood at Diagnosis and During the Course of Early Consolidation Treatment Correlates With Survival in Patients With Intermediate and Poor-Risk Acute Myeloid Leukemia2020 | First Faculty of Medicine
- ABC transporters are predictors of treatment failure in acute myeloid leukaemia2024 | First Faculty of Medicine, Faculty of Science
- Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients2023 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Treatment of adult patients with acute lymphoblastic leukemia in the Czech Republic in the period 2007–20202023 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Novel Somatic UBA1 Variant in a Patient With VEXAS Syndrome2023 | First Faculty of Medicine
- Tyrosinkinázové inhibitory tří generací v léčbě akutní lymfoblastové leukemie dospělých2023 | First Faculty of Medicine
- Low levels of minimal residual disease after induction chemotherapy for BCR-ABL1-negative acute lymphoblastic leukaemia in adults are clinically relevant2022 | First Faculty of Medicine, Second Faculty of Medicine
- A validation study of potential prognostic DNA methylation biomarkers in patients with acute myeloid leukemia using a custom DNA methylation sequencing panel2022 | First Faculty of Medicine, Faculty of Science
- NPM1 and DNMT3A mutations are associated with distinct blast immunophenotype in acute myeloid leukemia2022 | First Faculty of Medicine
Loading network view...